PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure.

about

PA21, a novel phosphate binder, improves renal osteodystrophy in rats with chronic renal failure.

Item

http://www.wikidata.org/entity/Q41007103

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

PA21, a novel phosphate binder ...... ts with chronic renal failure.

@en

type

Item

label

PA21, a novel phosphate binder ...... ts with chronic renal failure.

@en

prefLabel

PA21, a novel phosphate binder ...... ts with chronic renal failure.

@en

P1476

PA21, a novel phosphate binder ...... ts with chronic renal failure.

@en

P2093

Hiroo Takeda

http://www.w3.org/2001/XMLSchema#string

Mamoru Kobayashi

http://www.w3.org/2001/XMLSchema#string

Satoshi Tatemichi

http://www.w3.org/2001/XMLSchema#string

P2860

Hyperphosphatemia of chronic kidney disease

Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

Oral phosphate binders in patients with kidney failure

A model of the kinetics of lanthanum in human bone, using data collected during the clinical development of the phosphate binder lanthanum carbonate.

Phosphate - the silent stealthy cardiorenal culprit in all stages of chronic kidney disease: a systematic review.

Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?

A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients

Renal osteodystrophy, phosphate homeostasis, and vascular calcification.

Detection of Bone Metastases in Breast Cancer (BC) Patients by Serum Tartrate-Resistant Acid Phosphatase 5b (TRACP 5b), a Bone Resorption Marker and Serum Alkaline Phosphatase (ALP), a Bone Formation Marker, in Lieu of Whole Body Skeletal Scintigrap

FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality

P304

e0180430

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0180430

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

A Yaguchi

P577

2017-07-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28704404

http://www.w3.org/2001/XMLSchema#string

P932

5509238

http://www.w3.org/2001/XMLSchema#string